Lanosterol
Lanosterol | |
---|---|
Formula kimikoa | C30H50O |
SMILES kanonikoa | 2D eredua |
SMILES isomerikoa | C[C@H](CCC=C(C)C)[C@H]1CC[C@@]2([C@@]1(CCC3=C2CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)C)C |
MolView | 3D eredua |
Konposizioa | karbono |
Mota | Esterol eta [[(3S,10S,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol|(3S,10S,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol]] (en) |
Estereoisomeroa | (+)-tirucallol (en) , [[(3S,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2S)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol|(3S,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2S)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol]] (en) , [[(3S,5R,10S,13S,14S,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol|(3S,5R,10S,13S,14S,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol]] (en) , [[(3R,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2S)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol|(3R,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2S)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol]] (en) , [[(3S,5S,10S,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2S)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol|(3S,5S,10S,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2S)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol]] (en) , [[(3R,5R,10S,13S,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2S)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol|(3R,5R,10S,13S,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2S)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol]] (en) eta Euphol (en) |
Masa molekularra | 426,386 Da |
Erabilera | |
Rola | primary metabolite (en) |
Identifikatzaileak | |
InChlKey | CAHGCLMLTWQZNJ-BQNIITSRSA-N |
CAS zenbakia | 79-63-0 |
ChemSpider | 216175 |
PubChem | 246983 |
Reaxys | 2226449 |
Gmelin | 16521 |
ChEMBL | CHEMBL225111 |
EC zenbakia | 201-214-9 |
ECHA | 100.001.105 |
CosIng | 34865 |
MeSH | D007810 |
RxNorm | 1442199 |
Human Metabolome Database | HMDB0001251 |
KNApSAcK | C00003657 |
UNII | 1J05Z83K3M |
KEGG | C01724 |
PDB Ligand | LAN |
Lanosterola esterolen saileko alkohola da (C28H44O). Mutur batean daukan hidroxilo taldeari esker molekula anfipatikoa da.
Biosintesia
Eskualeno izeneko triterpenotik ekoizten da eta lanosterola oinarri hartuta eratzen dira gainerako esteroideak.
Osasuna
Azken ikerketek erakutsi dute ugaztunetan begi-lausoa edo "katarata" sortzea ekiditen duela[1].
Erreferentziak
- ↑ (Ingelesez) Zhang, Kang; Yan, Yong-Bin; Liu, Yizhi; Zhang, Liangfang; Wang, Jun; Sun, Xiaodong; Li, Yingrui; Granet, David et al.. (2015-07). «Lanosterol reverses protein aggregation in cataracts» Nature 523 (7562): 607–611. doi:10.1038/nature14650. ISSN 1476-4687. (Noiz kontsultatua: 2018-12-30).
Kanpo estekak
- Datuak: Q414996
- Multimedia: Lanosterol / Q414996
Lipidoak | ||
---|---|---|
|